Crosswalk Algorithms for Cognitive and Functional Outcomes Among 2013-2018 Medicare Beneficiaries With Dementia.

Autor: Pritchard KT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Mahesri M; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Chen Q; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Yang CT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Brill G; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kim DH; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA; Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, MA, USA., Lin KJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: jklin@bwh.harvard.edu.

Publikováno v: Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2024 Oct; Vol. 25 (10), pp. 105168. Date of Electronic Publication: 2024 Jul 25.

Identifying Dementia Severity Among People Living With Dementia Using Administrative Claims Data.

Autor: Anand P; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Zhang Y; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Harvard T. H. Chan School of Public Health, Boston, MA, USA., Ngan K; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Mahesri M; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Brill G; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kim DH; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA., Lin KJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: jklin@bwh.harvard.edu.

Publikováno v: Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2024 Sep; Vol. 25 (9), pp. 105129. Date of Electronic Publication: 2024 Jul 06.

Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan.

Autor: Feldman WB; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Mahesri M; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Sarpatwari A; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Zhu Y; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Hwang CS; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Lii J; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Lee SB; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Kattinakere Sreedhara S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Toyserkani GA; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Zhou EH; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Zendel L; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., LaCivita C; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Manzo C; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Dal Pan GJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Kesselheim AS; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Bykov K; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Jul 01; Vol. 7 (7), pp. e2419873. Date of Electronic Publication: 2024 Jul 01.

Identifying Functional Status Impairment in People Living With Dementia Through Natural Language Processing of Clinical Documents: Cross-Sectional Study.

Autor: Laurentiev J; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Kim DH; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA, United States., Mahesri M; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Wang KY; National Cheng Kung University Hospital, Tainan, Taiwan., Bessette LG; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., York C; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Zakoul H; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Lee SB; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Zhou L; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Lin KJ; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Massachusetts General Hospital, Boston, MA, United States.

Publikováno v: Journal of medical Internet research [J Med Internet Res] 2024 Feb 13; Vol. 26, pp. e47739. Date of Electronic Publication: 2024 Feb 13.

(629) - Renal Sparing Immunosuppression Regimens in Lung Transplant Recipients

Autor: Mahesri, M., Carns, M., Mohsin, S., Myers, C., Arunachalam, A., Bemiss, B., Tomic, R., Venkata Subramani, M.

Publikováno v: In Journal of Heart and Lung Transplantation April 2024 43(4) Supplement:S305-S305